Watch Demo

Estonia Antihypertensive Industry Outlook 2022 - 2026

See how Estonia Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Estonian sales of antihypertensive medicine are set to reach $2 million by 2026. In 2021, sales reached $1.8 million, growing at a rate of nearly 3% each year. Since 2004, demand in Estonia has grown 17% annually. In 2021, Estonia ranked 23rd in sales. New Zealand was ahead with $1.8 million, while Italy, Spain and Australia ranked second, third and fourth, respectively.

Estonia Antihypertensive Market Data and Forecasts

How much will Estonia Antihypertensive Market grow to 2026?

Forecast: Renin-Angiotensin System Medicine Sales in Estonia
Forecast: Renin-Angiotensin System Medicine Sales in Estonia
Forecast: Antihypertensive Medicine Sales in Estonia
Forecast: Antihypertensive Medicine Sales in Estonia
Forecast: Antihypertensive Medicine Sales in Estonia
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends